Stockreport

Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements

Estrella Immunopharma, Inc.  (ESLA) 
PDF EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing [Read more]